Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 116.56 million compared to CNY 135.64 million a year ago. Revenue was CNY 116.63 million compared to CNY 136.1 million a year ago.

Net income was CNY 20.74 million compared to CNY 23.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.2799 compared to CNY 0.3809 a year ago. Diluted earnings per share from continuing operations was CNY 0.2799 compared to CNY 0.3809 a year ago.